Pharmaceutical

Antitrust Investigation Targets Novo Nordisk and Sanofi Over Insulin Pricing in South Africa

1 day ago

In a significant development in the pharmaceutical sector, Danish pharmaceutical giant Novo Nordisk along with French company Sanofi is facing scrutiny from South African authorities concerning possible antitrust violations related to insulin pricing. The investigation aims to explore whether these companies engaged in unfair practices that may have contributed to the increased costs of insulin, a critical medication for diabetics, thus affecting public health.

AbbVie Launches Bold Entry into Obesity Treatment with Gubra Acquisition

3 days ago

In a significant move to broaden its portfolio and tap into the burgeoning obesity treatment market, pharmaceutical giant AbbVie has announced a strategic deal with Danish biotech firm Gubra, potentially worth up to $2.2 billion. This collaboration marks AbbVie's ambitious entry into a sector that has seen a surge in demand as obesity rates continue to rise globally.

Revolutionizing Medicine: DeepMind Set to Initiate Clinical Trials for AI-Crafted Pharmaceuticals

2 months ago

In a groundbreaking development in the field of medical science, DeepMind, a leading artificial intelligence (AI) research company owned by Alphabet Inc., has announced that it expects to commence clinical trials for drugs designed through AI technology within this calendar year. This move not only highlights the growing intersection of AI and healthcare but also exemplifies how advanced machine learning techniques are revolutionizing drug discovery.

UK Biotech Startup Ventures to Challenge Weight Loss Giants Novo and Lilly

2 months ago

A new player has entered the weight loss arena, taking aim at pharmaceutical powerhouses such as Novo Nordisk and Eli Lilly. This innovative UK biotech startup has unveiled ambitious plans to develop treatment alternatives that could potentially disrupt the current market dominated by these industry leaders.

Salesforce Steps Up Competition with Veeva by Targeting Pharmaceutical Customers

2 months ago

In a bold move to strengthen its foothold in the pharmaceutical sector, Salesforce has recently intensified its efforts to attract drug manufacturers away from its primary competitor, Veeva Systems. This strategic maneuver comes in light of Salesforce's ambitious plans to expand its offerings tailored specifically for the pharmaceutical industry, capitalizing on a growing demand for innovative customer relationship management solutions.

Enveda Secures $130 Million in Funding to Revolutionize Drug Discovery with AI Technology

4 months ago

Enveda, a promising startup in the realm of artificial intelligence-driven drug discovery, has successfully raised an impressive $130 million in its latest funding round. This substantial investment reflects growing confidence in the potential of AI capabilities to transform traditional pharmaceutical practices by significantly accelerating the process of discovering and developing new drugs.

Merck KGaA Surpasses Expectations Driven by Life Science Segment Growth

4 months ago

Merck KGaA, a globally recognized science and technology company, has reported better-than-expected financial results for the third quarter of 2024, attributing much of its success to a significant surge in its life science division. The company’s earnings indicate a robust performance that is likely to capture the attention of investors keen on biopharmaceuticals and lab technologies.

Novo Nordisk Harnesses Cutting-Edge NVIDIA Supercomputer to Accelerate Drug Discovery

5 months ago

Novo Nordisk, a global leader in diabetes care and biopharmaceutical innovation, has announced an ambitious partnership with NVIDIA to utilize its advanced supercomputing capabilities for the enhancement of drug discovery processes. This collaboration marks a significant step forward in the use of artificial intelligence and machine learning within the pharmaceutical industry, promising to expedite the development of novel therapies that could revolutionize patient care.

Novo Nordisk's Tough Month Causes Ripple Effect, Halts Health Stocks' Winning Streak

5 months ago

Of late, Novo Nordisk A/S, the powerhouse behind pharmaceuticals, has been facing hard times that eventually affected the broader health sector. This happens after health stocks had witnessed a record streak of gains.

Roche Aims to Deliver 20 New Drugs in Research Overhaul

5 months ago

The giant Swiss pharmaceutical company Roche Holding AG has announced an ambitious plan to deliver 20 new drugs as part of an extensive research overhaul. In a recent statement, the company announced its strategy in beefing up its innovation pipeline to address unmet medical needs across a wide array of therapeutic areas.